Similarly, AFP increased more than 30% at the onset of HCC in 19 of 39 patients (48.7%) with EOT-AFP ≥5.3 ng/mL, but only increased in two of 21 patients (9.5%) with EOT-AFP <5.3 ng/mL (p<0.001). Here, AFP is linked to hepatocellular carcinoma.